Table II.
Effect of Mometasone Treatments on the Cell Cycle Distribution in A549 Cells
Treatment | Percent cells | ||
---|---|---|---|
G0/G1 phase | G2/M phase | S phase | |
Untreated | 70 ± 1.3 | 5 ± 0.5 | 24 ± 2.5 |
Blank NP | 70 ± 0.9 | 4 ± 1.0 | 26 ± 1.9 |
MF | 76 ± 1.5 | 12 ± 1.2 | 10 ± 0.4 |
MF-NPs | 80 ± 0.6 | 11 ± 0.8 | 9 ± 0.2 |
WGA-MF-NPs | 84 ± 0.6 | 11 ± 0.5 | 5 ± 0.4 |
(Mean ± S.D., n = 3)
Blank NP Blank nanoparticles; MF mometasone furoate; MF-NPs mometasone furoate nanoparticles; WGA-MF-NPs WGA conjugated mometasone furoate nanoparticles